Literature DB >> 2345799

The role of macrophages in host defence mechanisms against Mycobacterium avium complex infection induced in mice.

H Saito1, H Tomioka.   

Abstract

Entities:  

Mesh：

Year:  1990        PMID： 2345799     DOI： 10.1016/0923-2508(90)90032-l

Source DB:  PubMed          Journal:  Res Microbiol        ISSN： 0923-2508            Impact factor:   3.992


× No keyword cloud information.
  6 in total

1.  Recombinant murine beta interferon enhances resistance of mice to systemic Mycobacterium avium infection.

Authors:  M Denis
Journal:  Infect Immun       Date:  1991-05       Impact factor: 3.441

2.  Roles of tumour necrosis factor-alpha (TNF-alpha), transforming growth factor-beta (TGF-beta), and IL-10 in the modulation of intercellular adhesion molecule-1 (ICAM-1) expression by macrophages during mycobacterial infection.

Authors:  H Tomioka; T Shimizu; W W Maw; K Ogasawara
Journal:  Clin Exp Immunol       Date:  2000-12       Impact factor: 4.330

3.  Chemotherapeutic efficacy of a newly synthesized benzoxazinorifamycin, KRM-1648, against Mycobacterium avium complex infection induced in mice.

Authors:  H Tomioka; H Saito; K Sato; T Yamane; K Yamashita; K Hosoe; K Fujii; T Hidaka
Journal:  Antimicrob Agents Chemother       Date:  1992-02       Impact factor: 5.191

4.  Therapeutic efficacy of the benzoxazinorifamycin KRM-1648 against experimental Mycobacterium avium infection induced in rabbits.

Authors:  M Emori; H Saito; K Sato; H Tomioka; T Setogawa; T Hidaka
Journal:  Antimicrob Agents Chemother       Date:  1993-04       Impact factor: 5.191

5.  H2O2 induces monocyte apoptosis and reduces viability of Mycobacterium avium-M. intracellulare within cultured human monocytes.

Authors:  P Laochumroonvorapong; S Paul; K B Elkon; G Kaplan
Journal:  Infect Immun       Date:  1996-02       Impact factor: 3.441

6.  Therapeutic effects of benzoxazinorifamycin KRM-1648 administered alone or in combination with a half-sized secretory leukocyte protease inhibitor or the nonsteroidal anti-inflammatory drug diclofenac sodium against Mycobacterium avium complex infection in mice.

Authors:  C Sano; T Shimizu; K Sato; H Kawauchi; S Kawahara; H Tomioka
Journal:  Antimicrob Agents Chemother       Date:  1999-02       Impact factor: 5.191
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.